Dr. Mark McGovern is a Professor of Psychiatry, of Community & Family Medicine, and of The Dartmouth Institute of Health Policy & Clinical Practice at the Geisel School of Medicine at Dartmouth in Lebanon New Hampshire. His clinical and research focus is integrated treatment for persons with co-occurring substance use and psychiatric disorders. Dr. McGovern has received a NIDA career development award and R01 grant funding to translate evidence-based therapies for co-occurring disorders into routine clinical settings. He has also received awards from the Robert Wood Johnson Foundation and the Substance Abuse and Mental Health Services Administration to advance a series of organizational measures of integrated service capacity. These measures, the Dual Diagnosis Capability in Addiction Treatment (DDCAT), Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) and Behavioral Health Integration in Medical Care (BHIMC), have been widely adopted and are being used to implement evidence-based treatments in community settings throughout the United States and globally. Dr. McGovern has been actively involved in the education of medical students, psychiatric residents and fellows, and clinical psychology interns at Dartmouth and previously at Northwestern University Medical School in Chicago, Illinois. Since 2009, he has been the Editor-In-Chief for the Journal of Substance Abuse Treatment (JSAT), the leading scientific journal dedicated to addiction treatment services and implementation research.
Last Updated: 3/31/15